Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
Clinical trial NCT01934894 · TERMINATED
Trial details
- NCT number
- NCT01934894
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-02-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.